Efficacy of Quantum NPWT With Simultaneous Irrigation on Reduction of Wound Volume in Stage III/IV Pressure Ulcers.
NCT ID: NCT01734109
Last Updated: 2012-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
90 participants
INTERVENTIONAL
2012-12-31
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard of Care - Wound Care
Standard, acceptable local wound care management, consisting of topical treatments, chemical debriders, or light bedside debridement.
No interventions assigned to this group
Quantum NPWT
Intervention with Quantum NPWT to Standard III/IV pressure ulcers for 12 weeks.
Quantum Negative Pressure Wound Therapy Device
To compare the additional benefit of Quantum Negative pressure wound therapy device with and without simultaneous irrigation.
Quantum NPWT with Irrigation
NPWT with the Quantum device, with the addition of simultaneous irrigation using 0.25% acetic acid.
Quantum Negative Pressure Wound Therapy Device
To compare the additional benefit of Quantum Negative pressure wound therapy device with and without simultaneous irrigation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quantum Negative Pressure Wound Therapy Device
To compare the additional benefit of Quantum Negative pressure wound therapy device with and without simultaneous irrigation.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Any patient with a stage III/IV pressure ulcer of the size large enough to indicate use of Negative Pressure Treatment.
Exclusion Criteria
* Patient or patient's guardian refuses consent.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Innovative Therapies, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sandra J Berriman, Ph.D.
Role: STUDY_DIRECTOR
Innovative Therapies, Inc.
Kenneth Moquin, MD
Role: PRINCIPAL_INVESTIGATOR
Henry Ford Hospital System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Henry Ford Hospital System
Detroit, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ITIQ002A
Identifier Type: -
Identifier Source: org_study_id